Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Lilly (Eli)
LLY Rank #12 Health Care
$1,027.59 -2.32%

Key Statistics

Market Cap
$969.73B
Volume (24h)
$3.3B
P/E Ratio
44.8
EPS
$22.94
1 Day
-2.32%
7 Day
+1.79%
YTD
+3.58%
Sector
Health Care
S&P 500 Rank
#12
52W Low: $908.60 52W High: $1,187.69

About Lilly (Eli)

Eli Lilly and Company is a multinational pharmaceutical corporation that develops, manufactures, and markets human pharmaceuticals and animal health products. The company's key products include diabetes treatments such as Humalog and Trulicity, cancer medications like Alimta and Cyramza, and mental health treatments like Prozac and Cymbalta. As a leading developer of innovative treatments, Eli Lilly plays a significant role in improving patient outcomes and advancing healthcare globally.

Latest News

Loading latest news...

Sector Peers — Health Care

JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% GILD — Gilead Sciences $149.58 +0.42% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.